AbbVie
ABBV
ABBV
2,241 hedge funds and large institutions have $94.8B invested in AbbVie in 2019 Q4 according to their latest regulatory filings, with 327 funds opening new positions, 830 increasing their positions, 830 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.75% more ownership
Funds ownership: 71.67% → 72.42% (+0.75%)
0% more repeat investments, than reductions
Existing positions increased: 830 | Existing positions reduced: 830
19% less call options, than puts
Call options by funds: $1.91B | Put options by funds: $2.37B
Holders
2,241
Holding in Top 10
113
Calls
$1.91B
Puts
$2.37B
Top Buyers
| 1 | +$736M | |
| 2 | +$401M | |
| 3 | +$398M | |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$306M |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
+$291M |
Top Sellers
| 1 | -$1.24B | |
| 2 | -$576M | |
| 3 | -$270M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$207M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$144M |